BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 18614586)

  • 1. Is there an optimal chemotherapy regimen for the treatment of advanced gastric cancer that will provide a platform for the introduction of new biological agents?
    Pozzo C; Barone C
    Oncologist; 2008 Jul; 13(7):794-806. PubMed ID: 18614586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Progress in chemotherapy for advanced gastric cancer].
    Xu RH; Teng KY
    Ai Zheng; 2009 Oct; 28(10):1108-13. PubMed ID: 19799823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemotherapy for advanced gastric cancer.
    Wagner AD; Syn NL; Moehler M; Grothe W; Yong WP; Tai BC; Ho J; Unverzagt S
    Cochrane Database Syst Rev; 2017 Aug; 8(8):CD004064. PubMed ID: 28850174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemotherapy of advanced gastric cancer.
    Rivera F; Vega-Villegas ME; López-Brea MF
    Cancer Treat Rev; 2007 Jun; 33(4):315-24. PubMed ID: 17376598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New perspectives in the treatment of advanced or metastatic gastric cancer.
    Rosati G; Ferrara D; Manzione L
    World J Gastroenterol; 2009 Jun; 15(22):2689-92. PubMed ID: 19522017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The choice of treatment in advanced gastric cancer].
    Pozzo C; Mansueto G
    Tumori; 2007; 93(6):suppl 11-21. PubMed ID: 18338512
    [No Abstract]   [Full Text] [Related]  

  • 7. Trastuzumab for the treatment of HER2-positive metastatic adenocarcinoma of the stomach or gastro-oesophageal junction.
    Norman G; Rice S; Spackman E; Stirk L; Danso-Appiah A; Suh D; Palmer S; Eastwood A
    Health Technol Assess; 2011 May; 15 Suppl 1():33-42. PubMed ID: 21609651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Capecitabine in the treatment of advanced gastric cancer.
    Lee JL; Kang YK
    Future Oncol; 2008 Apr; 4(2):179-98. PubMed ID: 18407732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An update on biochemotherapy of advanced gastric and gastroesophageal adenocarcinoma.
    Haghighat P; Bekaii-Saab T
    J Natl Compr Canc Netw; 2008 Oct; 6(9):895-900. PubMed ID: 18926099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-term efficacy of different chemotherapy regimens in the treatment of advanced gastric cancer: a network meta-analysis.
    Duo-Ji MM; Ci-Ren BS; Long ZW; Zhang XH; Luo DL
    Oncotarget; 2017 Jun; 8(23):37896-37911. PubMed ID: 28099947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Efficacy and Safety of First-line Chemotherapy in Advanced Esophagogastric Cancer: A Network Meta-analysis.
    Ter Veer E; Haj Mohammad N; van Valkenhoef G; Ngai LL; Mali RMA; Anderegg MC; van Oijen MGH; van Laarhoven HWM
    J Natl Cancer Inst; 2016 Oct; 108(10):. PubMed ID: 27576566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comprehensive review of S-1 in the treatment of advanced gastric adenocarcinoma.
    Blum M; Suzuki A; Ajani JA
    Future Oncol; 2011 Jun; 7(6):715-26. PubMed ID: 21675835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Capecitabine for the treatment of advanced gastric cancer.
    Norman G; Soares M; Peura P; Rice S; Suh D; Wright K; Sculpher M; Eastwood A
    Health Technol Assess; 2010 Oct; 14(Suppl. 2):11-7. PubMed ID: 21047486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A phase II study of docetaxel and oxaliplatin combination in recurrent gastric cancer patients after fluoropyrimidine and/or cisplatin adjuvant treatment: a Korean Cancer Study Group Protocol ST06-02.
    Choi YH; Oh SC; Kim JS; Nam SH; Kim BS; Cho SH; Chung IJ; Song EK; Yim CY; Baek JH; Jeung HC; Hong YS; Yang SH; Kang HJ
    Cancer Chemother Pharmacol; 2012 Nov; 70(5):665-72. PubMed ID: 22926638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of capecitabine and irinotecan combination therapy in advanced or metastatic gastric cancer.
    Farhat FS; Kattan J; Ghosn MG
    Expert Rev Anticancer Ther; 2010 Apr; 10(4):541-8. PubMed ID: 20397919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastric cancer. Treatment of advanced disease and new drugs.
    Caponigro F; Facchini G; Nasti G; Iaffaioli RV
    Front Biosci; 2005 Sep; 10():3122-6. PubMed ID: 15970566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Capecitabine for the treatment of gastric cancer.
    Kim TY; Oh DY; Bang YJ
    Expert Rev Gastroenterol Hepatol; 2015; 9(12):1471-81. PubMed ID: 26470733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemotherapy of metastatic colorectal cancer.
    Prescrire Int; 2010 Oct; 19(109):219-24. PubMed ID: 21180382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of new agents in the treatment of colorectal cancer.
    Folprecht G; Köhne CH
    Oncology; 2004; 66(1):1-17. PubMed ID: 15031593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemotherapy of metastatic colorectal cancer: fluorouracil plus folinic acid and irinotecan or oxaliplatin.
    Prescrire Int; 2005 Dec; 14(80):230-3. PubMed ID: 16400749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.